Algorae Pharmaceuticals Limited
OTC: LVCLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Richard Hainsworth
- Employees
- 48
- Headquarters
- Melbourne, Australia
- IPO year
- 2010
- Market cap
- $13.9M
- Website
- http://www.algoraepharma.com
Loading LVCLF…
Loading profile data…Frequently asked questions about LVCLF
What does Algorae Pharmaceuticals Limited (LVCLF) do?
Algorae Pharmaceuticals Limited, established in 1987 and based in Melbourne, Australia, is a pharmaceutical development company. The firm primarily conducts its research and development in New Zealand, focusing on living cell technologies. Its product pipeline includes several key candidates: AI-116, a novel combination therapy featuring cannabi...
Where does LVCLF trade?
Algorae Pharmaceuticals Limited (LVCLF) trades on the Other OTC.
What sector is LVCLF in?
Algorae Pharmaceuticals Limited (LVCLF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Algorae Pharmaceuticals Limited?
David Richard Hainsworth is the chief executive officer of Algorae Pharmaceuticals Limited (LVCLF).
Where is Algorae Pharmaceuticals Limited headquartered?
Algorae Pharmaceuticals Limited is headquartered in Australia.
Does LVCLF pay a dividend?
Algorae Pharmaceuticals Limited (LVCLF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LVCLF go public?
Algorae Pharmaceuticals Limited (LVCLF) completed its initial public offering in 2010.